
Fabino Life Sciences Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
Fabino Life Sciences Limited's completed its IPO journey with a successful listing on BSE on Jan 13, 2022. The public offering mobilized 9,00,000 Shares in total capital, comprising 9,00,000 Shares in fresh equity.
The offering was conducted within the price band of ₹36 to ₹36, with minimum application lots of 3000 shares. Investor participation during the Dec 31, 2021 to Jan 05, 2022 subscription window determined the final allocation pattern.
The basis of allotment was announced on Jan 10, 2022, finalizing share distribution to successful applicants. The listing represents a significant corporate development, providing the company with enhanced visibility and access to public capital markets.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Fabino Life Sciences is engaged in the manufacturing, marketing, trading and packing of pharmaceutical and wellness-focused consumer products, with a core focus on marketing pharmaceutical formulations in the domestic market through its own distribution network and sales force under the Fabino brand, while ayurvedic formulations are produced through loan licensing arrangements and handled for packing and labeling. The company also exports wellness and FMCG products such as coffee, malt powder, protein powder and hair care products, has over 70 active products across allopathic, Covid-19, food and wellness, herbal, veterinary and multivitamin segments, markets its shampoo and hair maintenance range under the Keepshine brand, and operates a manufacturing unit in the National Capital Region of India.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Experienced Promoter: Led by a promoter with strong pharmaceutical industry experience.
- Diverse Product Range: Offers a wide portfolio of products across categories.
- Strong Brand Protection: Holds over 70 registered product trademarks.
- Low Debt Position: Maintains a healthy balance sheet with minimal debt.
- Robust Distribution Network: Backed by a strong marketing and distribution setup.
NA
- Atul Kumar Jain
Fabino Life Sciences Limited
Bigshare Services Private Limited
